Nov 14, 2016 21:05 pm UTC| Business
HOUSTON, Nov. 14, 2016 -- Synthesis Energy Systems, Inc. (SES) (NASDAQ:SYMX), the global leader in low cost, high performance clean energy gasification technology, today reported financial and operating results for its...
Everspin Announces Third Quarter 2016 Financial Results
Nov 14, 2016 21:05 pm UTC| Business
CHANDLER, Ariz., Nov. 14, 2016 -- Everspin Technologies, Inc., (Nasdaq:MRAM), the world's leading developer and manufacturer of discrete and embedded Magnetoresistive Random Access Memory (MRAM), today announced...
Woodward Reports Fiscal Year 2016 Results and Fiscal Year 2017 Outlook
Nov 14, 2016 21:05 pm UTC| Business
FORT COLLINS, Colo., Nov. 14, 2016 -- Woodward, Inc. (NASDAQ:WWD) today reported financial results for its 2016 fiscal year and fourth quarter ending September 30, 2016. (All per share amounts are presented on a fully...
Cerner and American Well to Embed Telehealth Capabilities into Cerner EHR
Nov 14, 2016 21:05 pm UTC| Business
KANSAS CITY, Mo., Nov. 14, 2016 -- Cerner, a global leader in health care technology, today announced a telehealth agreement with American Well, a leading national telehealth company. Together, the companies will...
iRhythm Technologies to Report Third Quarter 2016 Financial Results on December 5, 2016
Nov 14, 2016 21:05 pm UTC| Business
SAN FRANCISCO, Nov. 14, 2016 -- iRhythm Technologies, Inc. (NASDAQ:IRTC),a leading digital health care solutions company focused on the advancement of cardiac care, today announced that it will release financial results...
Nov 14, 2016 21:05 pm UTC| Business
- Study is Evaluating Cavosonstat in Patients Heterozygous for F508del-CFTR and a Gating Mutation and Being Treated with Kalydeco™ - Data Expected in the First Quarter of 2017 BOULDER, Colo., Nov. 14, 2016 -- Nivalis...
Cyclacel Pharmaceuticals Reports 3rd Quarter 2016 Financial Results
Nov 14, 2016 21:05 pm UTC| Business
BERKELEY HEIGHTS, N.J., Nov. 14, 2016 -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target the various phases of...